Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers
NCT04108845Phase 1Unknown
- Sponsor
- Zhifei Green Bamboo
- Start
- Jun 2019
- Primary completion
- Aug 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 15-valent pneumococcal conjugate vaccine in Pneumococcal pneumonia (PP), sponsored by Zhifei Green Bamboo. Primary endpoints: Adverse events in 30 minutes, Solicited adverse events during 7 days and 5 more. Status: unknown.
02
Drugs
15-valent pneumococcal conjugate vaccine
03
Conditions
Pneumococcal pneumonia (PP)
Beyond the preview
Go deeper on NCT04108845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04108845.